STTR Phase I: Remote patient monitoring of medication fall risk in the elderly

STTR 第一阶段：远程患者​​监测老年人服药跌倒风险

• 批准号: 2013899
• 负责人: Norman Reeves
• 金额: $ 22.5万
• 依托单位: SUMAQ LIFE LLC
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-08-15 至 2021-07-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2013899&HistoricalAwards=false
• 关键词: STTR; Phase; Remote; patient; monitoring

The broader impact/commerical potential of this Small Business Innovation Research (SBIR) Phase I project will be a potentially significant reduction in medication-related falls, injuries, and deaths, as well as a reduction in fall-related medical costs. The number of older adults dying from falls increased by a factor of three between 2000 and 2016, with increased medication use possibly contributing to this alarming trend. Polypharmacy (i.e., taking 4 or more drugs) is growing with a 3-fold increase from 1992 to 2002. Since drugs are a modifiable risk factor, periodic medication reviews are recommended for fall prevention. This project will explore a new balance test involving target tracking to remotely monitor medication fall risk and allowing for timelier, personalized assessment of the risk of getting hurt.The Small Business Innovation Research (SBIR) Phase I project will advance a new balance test using target tracking. Technical work includes: 1) Confirm that the new test is sensitive to medication effects and is safe to perform; 2) Discriminate between fallers and non-fallers, thus demonstrating test validity; and 3) Compare test results with those of other tools.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

这项小型企业创新研究（SBIR）I阶段项目的更广泛的影响/商业潜力将是与药物有关的跌倒，伤害和死亡以及与跌倒有关的医疗费用的降低的潜在显着降低。 在2000年至2016年之间，死于跌倒的老年人的数量增加了三倍，使用药物的使用可能会导致这种令人震惊的趋势。 从1992年到2002年，多药剂（即服用4种或更多药物）正在增长3倍。由于药物是可修改的危险因素，因此建议对预防跌落进行定期药物审查。 该项目将探索涉及目标跟踪的新余额测试，以远程监控药物的跌落风险，并允许对受伤风险进行及时的个性化评估。小型企业创新研究（SBIR）I阶段项目将使用目标跟踪提高新的平衡测试。技术工作包括：1）确认新测试对药物效果敏感并且可以安全执行； 2）区分堕落者和非男人，从而证明了测试有效性； 3）将测试结果与其他工具的结果进行比较。该奖项反映了NSF的法定任务，并通过使用基金会的知识分子优点和更广泛的影响审查标准来评估值得支持。